Population pharmacokinetic analysis of crizotinib in children with progressive/recurrent high-grade and diffuse intrinsic pontine gliomas.

Gibson, Elizabeth G; Campagne, Olivia; Selvo, Nicholas S; Gajjar, Amar; Stewart, Clinton F

Gibson, Elizabeth G; Campagne, Olivia; Selvo, Nicholas S; Gajjar, Amar; Stewart, Clinton F.

Affiliation

Gibson EG; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA.
Campagne O; Bristol Myers Squibb, Princeton, NJ, USA.
Selvo NS; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA.
Gajjar A; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA.
Stewart CF; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.

Cancer Chemother Pharmacol ; 88(6): 1009-1020, 2021 12.

Article de En | MEDLINE | ID: mdl-34586478

Sujet(s)
Mots clés

Crizotinib; Dasatinib; High-grade glioma; Pediatric; Pharmacokinetic modeling

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du tronc cérébral / Crizotinib / Gliome infiltrant du tronc cérébral / Récidive tumorale locale / Antinéoplasiques Type d'étude: Observational_studies / Prognostic_studies Limites: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Langue: En Journal: Cancer Chemother Pharmacol Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google